ID   SIA8A_HUMAN             Reviewed;         356 AA.
AC   Q92185; A8K4H6; Q17RL0; Q6PZN5; Q93064;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1997, sequence version 1.
DT   10-MAY-2017, entry version 148.
DE   RecName: Full=Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase;
DE            EC=2.4.99.8;
DE   AltName: Full=Alpha-2,8-sialyltransferase 8A;
DE   AltName: Full=Ganglioside GD3 synthase;
DE   AltName: Full=Ganglioside GT3 synthase;
DE   AltName: Full=Sialyltransferase 8A;
DE            Short=SIAT8-A;
DE   AltName: Full=Sialyltransferase St8Sia I;
DE            Short=ST8SiaI;
GN   Name=ST8SIA1; Synonyms=SIAT8, SIAT8A;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, AND CATALYTIC
RP   ACTIVITY.
RC   TISSUE=Melanoma;
RX   PubMed=8195250;
RA   Sasaki K., Kurata K., Kojima N., Kurosawa N., Ohta S., Hanai N.,
RA   Tsuji S., Nishi T.;
RT   "Expression cloning of a GM3-specific alpha-2,8-sialyltransferase (GD3
RT   synthase).";
RL   J. Biol. Chem. 269:15950-15956(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, AND CATALYTIC
RP   ACTIVITY.
RC   TISSUE=Melanoma;
RX   PubMed=8058740; DOI=10.1073/pnas.91.17.7952;
RA   Nara K., Watanabe Y., Maruyama K., Kasahara K., Nagai Y., Sanai Y.;
RT   "Expression cloning of a CMP-NeuAc:NeuAc alpha 2-3Gal beta 1-4Glc beta
RT   1-1'Cer alpha 2,8-sialyltransferase (GD3 synthase) from human melanoma
RT   cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 91:7952-7956(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, CATALYTIC ACTIVITY,
RP   AND TISSUE SPECIFICITY.
RX   PubMed=7937974; DOI=10.1073/pnas.91.22.10455;
RA   Haraguchi M., Yamashiro S., Yamamoto A., Furukawa K., Takamiya K.,
RA   Lloyd K.O., Shiku H., Furukawa K.;
RT   "Isolation of GD3 synthase gene by expression cloning of GM3 alpha-
RT   2,8-sialyltransferase cDNA using anti-GD2 monoclonal antibody.";
RL   Proc. Natl. Acad. Sci. U.S.A. 91:10455-10459(1994).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, CATALYTIC ACTIVITY,
RP   AND TISSUE SPECIFICITY.
RX   PubMed=8631981;
RA   Nakayama J., Fukuda M.N., Hirabayashi Y., Kanamori A., Sasaki K.,
RA   Nishi T., Fukuda M.;
RT   "Expression cloning of a human GT3 synthase. GD3 and GT3 are
RT   synthesized by a single enzyme.";
RL   J. Biol. Chem. 271:3684-3691(1996).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND ALTERNATIVE SPLICING.
RA   Rimoldi S., Papis E., Bernardini G., Gornati R.;
RT   "Cloning of alternative human SAT-2 mRNA.";
RL   Submitted (MAR-2004) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND ALTERNATIVE SPLICING.
RA   Konta L., Laws S.M., Riemenschneider M., Adamski J.;
RT   "Alternative splice variant of the ST8SIA1 gene.";
RL   Submitted (JUL-2007) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Stomach, and Teratocarcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Colon;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [11]
RP   IDENTIFICATION.
RX   PubMed=15843597; DOI=10.1093/glycob/cwi063;
RA   Harduin-Lepers A., Mollicone R., Delannoy P., Oriol R.;
RT   "The animal sialyltransferases and sialyltransferase-related genes: a
RT   phylogenetic approach.";
RL   Glycobiology 15:805-817(2005).
CC   -!- FUNCTION: Involved in the production of gangliosides GD3 and GT3
CC       from GM3; gangliosides are a subfamily of complex
CC       glycosphinglolipds that contain one or more residues of sialic
CC       acid. {ECO:0000269|PubMed:7937974, ECO:0000269|PubMed:8058740,
CC       ECO:0000269|PubMed:8195250, ECO:0000269|PubMed:8631981}.
CC   -!- CATALYTIC ACTIVITY: CMP-N-acetylneuraminate + alpha-N-
CC       acetylneuraminyl-(2->3)-beta-D-galactosyl-R = CMP + alpha-N-
CC       acetylneuraminyl-(2->8)-alpha-N-acetylneuraminyl-(2->3)-beta-D-
CC       galactosyl-R. {ECO:0000269|PubMed:7937974,
CC       ECO:0000269|PubMed:8058740, ECO:0000269|PubMed:8195250,
CC       ECO:0000269|PubMed:8631981}.
CC   -!- PATHWAY: Protein modification; protein glycosylation.
CC   -!- PATHWAY: Lipid metabolism; sphingolipid metabolism.
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus membrane {ECO:0000305};
CC       Single-pass type II membrane protein {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q92185-1; Sequence=Displayed;
CC       Name=2; Synonyms=Sat-2;
CC         IsoId=Q92185-2; Sequence=VSP_047583, VSP_047584;
CC   -!- TISSUE SPECIFICITY: Strongly expressed in melanoma cell lines,
CC       adult and fetal brain and to a lesser extent in adult and fetal
CC       lung. {ECO:0000269|PubMed:7937974, ECO:0000269|PubMed:8631981}.
CC   -!- SIMILARITY: Belongs to the glycosyltransferase 29 family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC37586.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=CAA54891.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Functional Glycomics Gateway - GTase;
CC       Note=ST8Sia I;
CC       URL="http://www.functionalglycomics.org/glycomics/molecule/jsp/glycoEnzyme/viewGlycoEnzyme.jsp?gbpId=gt_hum_636";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X77922; CAA54891.1; ALT_INIT; mRNA.
DR   EMBL; D26360; BAA05391.1; -; mRNA.
DR   EMBL; L32867; AAA62366.1; -; mRNA.
DR   EMBL; L43494; AAC37586.1; ALT_INIT; mRNA.
DR   EMBL; AY569975; AAS75783.1; -; mRNA.
DR   EMBL; EU041716; ABU62753.1; -; mRNA.
DR   EMBL; AK290941; BAF83630.1; -; mRNA.
DR   EMBL; AK315340; BAG37739.1; -; mRNA.
DR   EMBL; AC007544; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC007671; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC053513; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC087318; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC138468; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471094; EAW96468.1; -; Genomic_DNA.
DR   EMBL; BC117285; AAI17286.1; -; mRNA.
DR   EMBL; BC126162; AAI26163.1; -; mRNA.
DR   CCDS; CCDS8697.1; -. [Q92185-1]
DR   PIR; A54032; A54032.
DR   RefSeq; NP_001291379.1; NM_001304450.1.
DR   RefSeq; NP_003025.1; NM_003034.3. [Q92185-1]
DR   UniGene; Hs.408614; -.
DR   ProteinModelPortal; Q92185; -.
DR   SMR; Q92185; -.
DR   BioGrid; 112380; 10.
DR   STRING; 9606.ENSP00000379353; -.
DR   SwissLipids; SLP:000000749; -.
DR   SwissLipids; SLP:000000871; -.
DR   CAZy; GT29; Glycosyltransferase Family 29.
DR   iPTMnet; Q92185; -.
DR   PhosphoSitePlus; Q92185; -.
DR   BioMuta; ST8SIA1; -.
DR   PaxDb; Q92185; -.
DR   PeptideAtlas; Q92185; -.
DR   PRIDE; Q92185; -.
DR   DNASU; 6489; -.
DR   Ensembl; ENST00000261197; ENSP00000261197; ENSG00000111728. [Q92185-2]
DR   Ensembl; ENST00000396037; ENSP00000379353; ENSG00000111728. [Q92185-1]
DR   GeneID; 6489; -.
DR   KEGG; hsa:6489; -.
DR   UCSC; uc001rfo.4; human. [Q92185-1]
DR   CTD; 6489; -.
DR   DisGeNET; 6489; -.
DR   GeneCards; ST8SIA1; -.
DR   HGNC; HGNC:10869; ST8SIA1.
DR   HPA; HPA026775; -.
DR   MIM; 601123; gene.
DR   neXtProt; NX_Q92185; -.
DR   OpenTargets; ENSG00000111728; -.
DR   PharmGKB; PA35770; -.
DR   eggNOG; KOG2692; Eukaryota.
DR   eggNOG; ENOG410XT8P; LUCA.
DR   GeneTree; ENSGT00550000074407; -.
DR   HOGENOM; HOG000090201; -.
DR   HOVERGEN; HBG106106; -.
DR   InParanoid; Q92185; -.
DR   KO; K03371; -.
DR   OMA; CWLYVFP; -.
DR   OrthoDB; EOG091G0CER; -.
DR   PhylomeDB; Q92185; -.
DR   TreeFam; TF323961; -.
DR   BRENDA; 2.4.99.8; 2681.
DR   Reactome; R-HSA-4085001; Sialic acid metabolism.
DR   UniPathway; UPA00222; -.
DR   UniPathway; UPA00378; -.
DR   ChiTaRS; ST8SIA1; human.
DR   GeneWiki; ST8SIA1; -.
DR   GenomeRNAi; 6489; -.
DR   PRO; PR:Q92185; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000111728; -.
DR   CleanEx; HS_ST8SIA1; -.
DR   ExpressionAtlas; Q92185; baseline and differential.
DR   Genevisible; Q92185; HS.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0030173; C:integral component of Golgi membrane; IEA:InterPro.
DR   GO; GO:0016021; C:integral component of membrane; TAS:ProtInc.
DR   GO; GO:0003828; F:alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity; TAS:Reactome.
DR   GO; GO:0008373; F:sialyltransferase activity; TAS:ProtInc.
DR   GO; GO:0005975; P:carbohydrate metabolic process; TAS:ProtInc.
DR   GO; GO:0034605; P:cellular response to heat; IEA:Ensembl.
DR   GO; GO:0006688; P:glycosphingolipid biosynthetic process; TAS:ProtInc.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl.
DR   GO; GO:0006486; P:protein glycosylation; IEA:UniProtKB-UniPathway.
DR   InterPro; IPR001675; Glyco_trans_29.
DR   InterPro; IPR012163; Sialyl_trans.
DR   Pfam; PF00777; Glyco_transf_29; 1.
DR   PIRSF; PIRSF005557; Sialyl_trans; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Disulfide bond; Glycoprotein;
KW   Glycosyltransferase; Golgi apparatus; Lipid metabolism; Membrane;
KW   Reference proteome; Signal-anchor; Sphingolipid metabolism;
KW   Transferase; Transmembrane; Transmembrane helix.
FT   CHAIN         1    356       Alpha-N-acetylneuraminide alpha-2,8-
FT                                sialyltransferase.
FT                                /FTId=PRO_0000149282.
FT   TOPO_DOM      1     29       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     30     48       Helical; Signal-anchor for type II
FT                                membrane protein. {ECO:0000255}.
FT   TOPO_DOM     49    356       Lumenal. {ECO:0000255}.
FT   REGION      188    190       Substrate binding.
FT                                {ECO:0000250|UniProtKB:O43173}.
FT   REGION      274    276       Substrate binding.
FT                                {ECO:0000250|UniProtKB:O43173}.
FT   ACT_SITE    322    322       Proton donor/acceptor.
FT                                {ECO:0000250|UniProtKB:O43173}.
FT   BINDING     166    166       Substrate.
FT                                {ECO:0000250|UniProtKB:O43173}.
FT   CARBOHYD     71     71       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    119    119       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    214    214       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    245    245       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    138    287       {ECO:0000250|UniProtKB:O43173}.
FT   DISULFID    152    347       {ECO:0000250|UniProtKB:O43173}.
FT   VAR_SEQ     128    135       ATPFQLPL -> MQSPSFVK (in isoform 2).
FT                                {ECO:0000303|Ref.5, ECO:0000303|Ref.6}.
FT                                /FTId=VSP_047583.
FT   VAR_SEQ     136    356       Missing (in isoform 2).
FT                                {ECO:0000303|Ref.5, ECO:0000303|Ref.6}.
FT                                /FTId=VSP_047584.
SQ   SEQUENCE   356 AA;  40519 MW;  452FE04856964395 CRC64;
     MSPCGRARRQ TSRGAMAVLA WKFPRTRLPM GASALCVVVL CWLYIFPVYR LPNEKEIVQG
     VLQQGTAWRR NQTAARAFRK QMEDCCDPAH LFAMTKMNSP MGKSMWYDGE FLYSFTIDNS
     TYSLFPQATP FQLPLKKCAV VGNGGILKKS GCGRQIDEAN FVMRCNLPPL SSEYTKDVGS
     KSQLVTANPS IIRQRFQNLL WSRKTFVDNM KIYNHSYIYM PAFSMKTGTE PSLRVYYTLS
     DVGANQTVLF ANPNFLRSIG KFWKSRGIHA KRLSTGLFLV SAALGLCEEV AIYGFWPFSV
     NMHEQPISHH YYDNVLPFSG FHAMPEEFLQ LWYLHKIGAL RMQLDPCEDT SLQPTS
//
